
Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
Author(s) -
Kumar Anshuman,
Dhanashree Ratra
Publication year - 2019
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_204_19
Subject(s) - ranibizumab , medicine , aflibercept , ophthalmology , bevacizumab , visual acuity , fluorescein angiography , verteporfin , serous fluid , macular degeneration , retinal pigment epithelium , vascular endothelial growth factor , retinal , pathology , choroidal neovascularization , surgery , vegf receptors , chemotherapy